Karin Eastham - Net Worth and Insider Trading

Karin Eastham Net Worth

The estimated net worth of Karin Eastham is at least $2 Million dollars as of 2024-12-01. Karin Eastham is the Director of Illumina Inc and owns about 10,838 shares of Illumina Inc (ILMN) stock worth over $2 Million. Karin Eastham is the Director of Veracyte Inc and owns about 18,497 shares of Veracyte Inc (VCYT) stock worth over $794,446. Karin Eastham is also the Director of Nektar Therapeutics and owns about 13,033 shares of Nektar Therapeutics (NKTR) stock worth over $14,858. Details can be seen in Karin Eastham's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karin Eastham has not made any transactions after 2024-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Karin Eastham

To

Karin Eastham Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Karin Eastham owns 5 companies in total, including Nektar Therapeutics (NKTR) , Veracyte Inc (VCYT) , and Geron Corp (GERN) among others .

Click here to see the complete history of Karin Eastham’s form 4 insider trades.

Insider Ownership Summary of Karin Eastham

Ticker Comapny Transaction Date Type of Owner
NKTR Nektar Therapeutics 2022-09-13 director
VCYT Veracyte Inc 2024-11-19 director
GERN Geron Corp 2009-03-30 director
LIMIT LIMIT 2019-09-09 director
LIMIT LIMIT 2019-01-02 director

Karin Eastham Latest Holdings Summary

Karin Eastham currently owns a total of 3 stocks. Among these stocks, Karin Eastham owns 10,838 shares of Illumina Inc (ILMN) as of January 2, 2019, with a value of $2 Million and a weighting of 65.88%. Karin Eastham owns 18,497 shares of Veracyte Inc (VCYT) as of November 19, 2024, with a value of $794,446 and a weighting of 33.5%. Karin Eastham also owns 13,033 shares of Nektar Therapeutics (NKTR) as of September 13, 2022, with a value of $14,858 and a weighting of 0.63%.

Latest Holdings of Karin Eastham

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ILMN Illumina Inc 2019-01-02 10,838 144.15 1,562,298
VCYT Veracyte Inc 2024-11-19 18,497 42.95 794,446
NKTR Nektar Therapeutics 2022-09-13 13,033 1.14 14,858

Holding Weightings of Karin Eastham


Karin Eastham Form 4 Trading Tracker

According to the SEC Form 4 filings, Karin Eastham has made a total of 0 transactions in Illumina Inc (ILMN) over the past 5 years. The most-recent trade in Illumina Inc is the sale of 5,000 shares on January 2, 2019, which brought Karin Eastham around $1 Million.

According to the SEC Form 4 filings, Karin Eastham has made a total of 10 transactions in Veracyte Inc (VCYT) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Veracyte Inc is the sale of 14,731 shares on November 19, 2024, which brought Karin Eastham around $564,787.

According to the SEC Form 4 filings, Karin Eastham has made a total of 1 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Nektar Therapeutics is the sale of 21,267 shares on September 13, 2022, which brought Karin Eastham around $76,774.

Insider Trading History of Karin Eastham

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Karin Eastham Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Karin Eastham Ownership Network

Ownership Network List of Karin Eastham

No Data

Ownership Network Relation of Karin Eastham

Insider Network Chart

Karin Eastham Owned Company Details

What does Nektar Therapeutics do?

Who are the key executives at Nektar Therapeutics?

Karin Eastham is the director of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .

Nektar Therapeutics (NKTR) Insider Trades Summary

Over the past 18 months, Karin Eastham made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 107,717 shares made by Howard W Robin , a net sale of 50,369 shares made by Jonathan Zalevsky , and a net sale of 40,324 shares made by Mark Andrew Wilson .

In summary, during the past 3 months, insiders sold 30,470 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 30,470 shares. During the past 18 months, 282,628 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 282,628 shares.

Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nektar Therapeutics Insider Transactions

No Available Data

Karin Eastham Mailing Address

Above is the net worth, insider trading, and ownership report for Karin Eastham. You might contact Karin Eastham via mailing address: C/o Burnham Institute For Medical Resear, 10901 N. Torrey Pines Road, La Jolla Ca 92037.

Discussions on Karin Eastham

No discussions yet.